首页 | 本学科首页   官方微博 | 高级检索  
     

DNA甲基化在骨质疏松症中的研究进展
引用本文:潘晓豪 周展毅 凌奕清 厉驹 徐涛涛. DNA甲基化在骨质疏松症中的研究进展[J]. 中国骨质疏松杂志, 2022, 0(1): 114-119
作者姓名:潘晓豪 周展毅 凌奕清 厉驹 徐涛涛
作者单位:浙江中医药大学第一临床医学院;浙江中医药大学附属第一医院
基金项目:国家自然科学基金(81904223);浙江省医药卫生科技计划项目(2020KY659)。
摘    要:
骨质疏松症是以骨微结构退化、强度下降为主要变化的骨骼疾病,常导致骨折的发生.它通常是由骨吸收增加,而骨形成的相应增加不能充分代偿所引起的.骨质疏松症常常由多因素引起,其中遗传因素对于峰值骨量、骨结构以及骨骼恶化和脆性骨折的易感性至关重要.然而,仅遗传因素不足以解释骨质疏松症的发生发展以及脆性骨折的发生.目前表观遗传因素...

关 键 词:DNA甲基化  骨质疏松症  成骨细胞  破骨细胞  间充质干细胞

Research progress of DNA methylation in osteoporosis
PAN Xiaohao,ZHOU Zhanyi,LING Yiqing,LI Ju,XU Taotao. Research progress of DNA methylation in osteoporosis[J]. Chinese Journal of Osteoporosis, 2022, 0(1): 114-119
Authors:PAN Xiaohao  ZHOU Zhanyi  LING Yiqing  LI Ju  XU Taotao
Affiliation:(The First Clinical Medical College of Zhejiang Chinese Medicine University,Hangzhou 310053;The First Affiliated Hospital of Zhejiang Chinese Medicine University,Hangzhou 310006,China)
Abstract:
Osteoporosis is a bone disease in which bone microstructure degradation and strength decrease are the main changes, which often lead to fractures. It is usually caused by increased bone resorption, and the corresponding increase in bone formation cannot fully compensate. Osteoporosis is often caused by multiple factors, among which genetic factors are critical to peak bone mass, bone structure, and susceptibility to bone deterioration and fragility fractures. However, genetic factors alone are not enough to explain the occurrence and development of osteoporosis and the occurrence of fragility fractures. At present, epigenetic factors are considered to be closely related to osteoporosis, and it has been confirmed that bone metabolism is regulated by epigenetic mechanisms. DNA methylation, an important component of epigenetics, affects the occurrence and development of osteoporosis by regulating the expression of osteoporosis-related genes. This article reviews the mechanism of DNA methylation on osteoblasts, osteoclasts, and mesenchymal stem cells, and explores the significance and possibility of using DNA methylation as a biomarker for the diagnosis and treatment of osteoporosis.
Keywords:DNA methylation  osteoporosis  osteoblasts  osteoclasts  mesenchymal stem cells
本文献已被 维普 等数据库收录!
点击此处可从《中国骨质疏松杂志》浏览原始摘要信息
点击此处可从《中国骨质疏松杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号